New Enroll in RBI Grade B New Batch - Starts on May 21

    Question

    Recently which of the following institutions has entered

    into an agreement with Biovet Private Ltd. for the commercial production of the indigenous vaccine of Lumpy Skin Disease (LSD) called ‘Lumpi-ProVacind’?
    A DRDO Correct Answer Incorrect Answer
    B ICAR Correct Answer Incorrect Answer
    C Serum Institute Correct Answer Incorrect Answer
    D National Institute of Virology Correct Answer Incorrect Answer
    E None of the above Correct Answer Incorrect Answer

    Solution

    The Indian Council of Agriculture Research (ICAR) has recently entered into an agreement with Biovet Private Ltd. for the commercial production of the indigenous vaccine of Lumpy Skin Disease (LSD) called ‘Lumpi-ProVacind’. Lumpi-ProVacInd – jointly developed by ICAR’s National Research Centre on Equines (NRCE) at Hisar, Haryana and the Indian Veterinary Research Institute (IVRI) at Izatnagar, UP — is a live attenuated vaccine, similar to those used against tuberculosis, measles, mumps and rubella. Learn Along: The ICAR is an autonomous organisation under the Department of Agricultural Research and Education (DARE), Ministry of Agriculture and Farmers Welfare ICAR Headquarters: New Delhi Director General: Trilochan Mohapatra Biovet Pvt. Ltd Headquarters: Malur,Karnataka MD: Shree Narayan Singh

    Practice Next

    Relevant for Exams: